The Female Condom as HIV Prevention

The Female Condom

While the female condom has been available for 30 years, research questions remain in regards to design, rollout and implementation. R&D work— including product development efforts, basic HIV research, clinical trial preparation, community education and advocacy—continues. In 2011, global investment in R&D related to the female condom totaled US$1.2 million, coming from the US NIH and the Female Condom Company.


HIV Vaccines and Microbicides Resource Tracking Working Group

All Content © 2000 - 2013 HIV Resource Tracking. Website Maintained by Progress Technology, Inc.
Log In / Administration